Evicenter
P&T meetings

Aqneursa (levacetylleucine)

Ataxia-telangiectasia

Also known as IB1001
Manufacturer
IntraBio
Last updated
206 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Incidence of Ataxia-telangiectasia

4 evidence topics · 6 sources

United States birth incidence: nationwide case finding
MeasureEstimate
Cases identified in 1970 to 1972 and 1980 to 1984“231 white, 29 black, and three Oriental A-T cases”
Birth rate of identified white patients, 1965 to 1969“3.0 per million live births”
Highest observed state incidence (Michigan, 1965 to 1969)“11.3 per million births”
United Kingdom birth frequency

“A prevalence study of ataxia telangiectasia was conducted in the West Midlands, with a population of over 5 million. The prevalence in those aged 50 or less was found to be 1 in 514,000 and the birth frequency to be about 1 in 300,000.” (opens the source at this quote in a new tab)

Range of reported incidence

“The reported incidence of A-T, a rare disorder, varies between 1:300,000 and 1:40,000.” (opens the source at this quote in a new tab)

“The world-wide prevalence of A-T is estimated to be between 1 in 40,000 and 1 in 100,000 live births.” (opens the source at this quote in a new tab)

“With the exception of consanguineous populations, individuals of all races and ethnicities are affected equally by A-T.” (opens the source at this quote in a new tab)

United States estimate per live births

“In the United States, the prevalence of AT is approximately 1:40,000 to 1:100,000 live births. Males and females are affected in equal numbers. Certain ethnic groups may have a higher prevalence of AT due to a founder effect.” (opens the source at this quote in a new tab)